Sciampa-M 12.5mg+500mg – Empagliflozin+Metformin Diabetes
Sciampa-M 12.5mg+500mg Tablets combine Empagliflozin (SGLT2 inhibitor) and Metformin (biguanide) for comprehensive type 2 diabetes management through two complementary mechanisms. Empagliflozin promotes urinary glucose excretion while Metformin reduces hepatic glucose production and improves insulin sensitivity. Requires a valid prescription.
Pay in 3 Installments of
Rs.
171
Sciampa-m 12.5mg+500mg – Empagliflozin+metformin Diabetes
Description
Sciampa-M 12.5mg+500mg Tablets provide a fixed-dose combination of Empagliflozin (12.5mg), an SGLT2 inhibitor, and Metformin (500mg), a biguanide — the two most complementary oral anti-diabetic agents in current type 2 diabetes management. Together they lower blood glucose through two distinct mechanisms for robust glycaemic control.
Empagliflozin blocks SGLT2 receptors in the renal tubules, promoting urinary glucose excretion independent of insulin. Metformin reduces hepatic glucose production, improves peripheral insulin sensitivity, and decreases intestinal glucose absorption. This synergistic combination also confers cardiovascular protective effects, including reduced risk of major adverse cardiac events and heart failure hospitalisation.
Sciampa-M is indicated for adults with type 2 diabetes mellitus whose blood glucose is inadequately controlled on diet, exercise, or single-agent therapy. It should be taken as prescribed, with meals to minimise gastrointestinal side effects, under regular medical monitoring of renal function and HbA1c.
Order Sciampa-M 12.5mg+500mg Tablets from Derma.pk with a valid prescription. See all diabetes medicines available in Pakistan on our platform.
Usage & Benefits
- Dual-mechanism glycaemic control: SGLT2 inhibition + hepatic glucose suppression
- Promotes urinary glucose excretion independent of insulin secretion
- Improves insulin sensitivity and reduces hepatic glucose production
- Confers cardiovascular protective effects including reduced heart failure hospitalisation
- Once or twice daily dosing for simplified T2DM management
How To Use
1. Take Sciampa-M tablets as prescribed, preferably with meals to reduce gastrointestinal discomfort.
2. Swallow whole with a glass of water — do not crush or chew.
3. Monitor blood glucose regularly as directed by your doctor.
4. Maintain prescribed diet and exercise regimen alongside medication.
5. Attend regular kidney function, HbA1c, and liver function monitoring appointments.
Use only as directed by your healthcare provider.
FAQs
What is Sciampa-M 12.5mg+500mg used for?
It manages blood sugar in adults with type 2 diabetes mellitus whose glucose is not adequately controlled on lifestyle measures or single-agent therapy.
How does Empagliflozin in Sciampa-M help diabetes?
Empagliflozin blocks SGLT2 receptors in the kidneys, causing excess glucose to be excreted in urine, which lowers blood sugar without stimulating insulin release.
Are there any special precautions for Sciampa-M?
Patients with significant kidney impairment should not use this medication. Regular renal function monitoring is required, and patients should stay well hydrated to reduce UTI risk.



